bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aorta.
In animal models, a hypercholesterolemic diet induces areas of deendothelialization and impairs endothelium-dependent vasorelaxation. Angiogenic growth factors increase endothelial cell growth in vivo. This study was thus designed to test the hypothesis that chronic administration of basic fibroblast growth factor (bFGF) in hypercholesterolemic rabbits might restore normal physiological responses to endothelium-dependent agonists. After feeding on a 2% cholesterol diet for 6 wk, 14 New Zealand White rabbits received twice-weekly intravenous boluses of either 2.5 microg bFGF (hypercholesterolemic bFGF group, n = 6) or placebo (hypercholesterolemic control group, n = 8) for 3 wk and were killed for assessment of in vitro vasoreactivity and for histological analysis. Six animals fed with standard rabbit diet were used to assess normal responses. Endothelium-dependent responses to acetylcholine and to the calcium ionophore A-23187 were reduced in the hypercholesterolemic control group compared with normal rabbits. Hypercholesterolemic animals treated with bFGF had significantly better endothelium-dependent responses than hypercholesterolemic rabbits not treated with bFGF. Endothelium-independent responses did not differ significantly among the three groups. A similar degree of plaque formation was observed in control- and bFGF-treated hypercholesterolemic rabbits. These results show that, in this model of atherosclerosis, bFGF has a highly beneficial effect on the functional responses of atherosclerotic vessels and does not have a deleterious effect on the degree of plaque formation.
Meurice
T
T
Department of Pharmacology, University of Lille, France.
Bauters
C
C
Vallet
B
B
Corseaux
D
D
van Belle
E
E
Hamon
M
M
Dupuis
B
B
Lablanche
J M
JM
Bertrand
M E
ME
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D000001:Calcimycin / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology*; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006937:Hypercholesterolemia / Q000473:pathology / Q000503:physiopathology*; D007476:Ionophores / Q000494:pharmacology; D008297:Male; D011817:Rabbits; D012016:Reference Values; D014664:Vasodilation
D007476:Ionophores; D016222:Fibroblast Growth Factor 2; D000001:Calcimycin; D000109:Acetylcholine